$74.76
1.16% yesterday
NYSE, Sep 27, 10:10 pm CET
ISIN
US2074101013
Symbol
CNMD

Conmed Corp. Stock price

$74.76
+2.14 2.95% 1M
-5.38 6.71% 6M
-34.75 31.73% YTD
-22.79 23.36% 1Y
-56.56 43.07% 3Y
-21.14 22.04% 5Y
+36.93 97.62% 10Y
NYSE, Closing price Fri, Sep 27 2024
+0.86 1.16%
ISIN
US2074101013
Symbol
CNMD
Sector

Key metrics

Market capitalization $2.28b
Enterprise Value $3.22b
P/E (TTM) P/E ratio 23.51
EV/FCF (TTM) EV/FCF 20.21
EV/Sales (TTM) EV/Sales 2.53
P/S ratio (TTM) P/S ratio 1.79
P/B ratio (TTM) P/B ratio 2.58
Dividend yield 1.08%
Last dividend (FY23) $0.80
Revenue growth (TTM) Revenue growth 12.77%
Revenue (TTM) Revenue $1.27b
EBIT (operating result TTM) EBIT $152.08m
Free Cash Flow (TTM) Free Cash Flow $159.08m
Cash position $28.87m
EPS (TTM) EPS $3.14
P/E forward 19.37
P/S forward 1.74
EV/Sales forward 2.46
Short interest 13.69%
Show more

Is Conmed Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Conmed Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Conmed Corp. forecast:

5x Buy
63%
3x Hold
38%

Analyst Opinions

8 Analysts have issued a Conmed Corp. forecast:

Buy
63%
Hold
38%

Financial data from Conmed Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
1,272 1,272
13% 13%
100%
- Direct Costs 612 612
10% 10%
48%
660 660
15% 15%
52%
- Selling and Administrative Expenses 397 397
1% 1%
31%
- Research and Development Expense 54 54
6% 6%
4%
208 208
63% 63%
16%
- Depreciation and Amortization 56 56
0% 0%
4%
EBIT (Operating Income) EBIT 152 152
112% 112%
12%
Net Profit 99 99
12% 12%
8%

In millions USD.

Don't miss a Thing! We will send you all news about Conmed Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Conmed Corp. Stock News

Neutral
GlobeNewsWire
15 days ago
Dublin, Sept. 12, 2024 (GLOBE NEWSWIRE) -- The "Carpal Tunnel Release Systems - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Carpal Tunnel Release Systems was estimated at US$604.4 Million in 2023, and is projected to reach US$809.7 Million by 2030, growing at a CAGR of 4.3% from 2023 to 2030. The growth in the carpal tunnel releas...
Neutral
Business Wire
about one month ago
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Wells Fargo Healthcare Conference at 8:00 a.m. ET on Wednesday, September 4, 2024. A live webcast of the fireside chat w...
Neutral
Business Wire
about 2 months ago
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on August 8, 2024, payable on October 4, 2024, to all shareholders of record as of September 16, 2024. About CONMED Corporation CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Compa...
More Conmed Corp. News

Company Profile

CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States; Americas excluding the United States; Europe, Middle East, and Africa; and Asia Pacific. Its products are used by surgeons and physicians in a variety of medical specialties, including orthopedic surgery, general surgery, gynecology, neurosurgery, thoracic surgery and gastroenterology. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

Head office United States
CEO Curt Hartman
Employees 4,000
Founded 1970
Website www.conmed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today